| 产品描述: | Terutroban is a thromboxane-prostaglandin receptor antagonist. |
| 靶点: |
Prostaglandin Receptor;ProstaglandinReceptor |
| 体内研究: |
Terutroban(30 mg/kg;灌胃;每日 1 次;6 周)在自发性高血压易卒中型大鼠(SHRSPs)中,得出防止主动脉增厚、抑制血管细胞增殖、减少血管纤维化、HSP47 和 TGF-1β 表达且不影响血压的结果。 |
| 参考文献: |
1. De La Cruz JP, et al. Effects of terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, on retinal vascularity in diabetic rats. Diabetes Metab Res Rev. 2012 Feb;28(2):132-138. 2. Bots ML, et al. Thromboxane prostaglandin receptor antagonist and carotid atherosclerosis progression in patients with cerebrovascular disease of ischemic origin: a randomized controlled trial. Stroke. 2014 Aug;45(8):2348-2353. 3. Lesault PF, et al. Daily administration of the TP receptor antagonist terutroban improved endothelial function in high-cardiovascular-risk patients with atherosclerosis. Br J Clin Pharmacol.2011 Jun;71(6):844-851. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
2-8℃ |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.452 ml |
12.258 ml |
24.515 ml |
| 5 mM |
0.49 ml |
2.452 ml |
4.903 ml |
| 10 mM |
0.245 ml |
1.226 ml |
2.452 ml |
| 50 mM |
0.049 ml |
0.245 ml |
0.49 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |